MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy
RV Lalla, J Bowen, A Barasch, L Elting, J Epstein… - Cancer, 2014 - Wiley Online Library
BACKGROUND Mucositis is a highly significant, and sometimes dose‐limiting, toxicity of
cancer therapy. The goal of this systematic review was to update the Multinational …
cancer therapy. The goal of this systematic review was to update the Multinational …
Oral complications of cancer and cancer therapy: from cancer treatment to survivorship
JB Epstein, J Thariat, RJ Bensadoun… - CA: a cancer journal …, 2012 - Wiley Online Library
Answer questions and earn CME/CNE Oral complications resulting from cancer and cancer
therapies cause acute and late toxicities that may be underreported, underrecognized, and …
therapies cause acute and late toxicities that may be underreported, underrecognized, and …
[HTML][HTML] Understanding chemotherapy-induced intestinal mucositis and strategies to improve gut resilience
Intestinal mucositis remains one of the most debilitating side effects related to
chemotherapy. The onset and persistence of mucositis is an intricate physiological process …
chemotherapy. The onset and persistence of mucositis is an intricate physiological process …
Bisphosphonate-related osteonecrosis of the jaw: is pH the missing part in the pathogenesis puzzle?
S Otto, S Hafner, G Mast, T Tischer, E Volkmer… - Journal of Oral and …, 2010 - Elsevier
Bisphosphonate-related osteonecrosis of the jaw (BRONJ) is a side effect of
bisphosphonate therapy, primarily diagnosed in patients with cancer and metastatic bone …
bisphosphonate therapy, primarily diagnosed in patients with cancer and metastatic bone …
Metal complex strategies for photo-uncaging the small molecule bioregulators nitric oxide and carbon monoxide
PC Ford - Coordination Chemistry Reviews, 2018 - Elsevier
Photochemical release (uncaging) of small molecule bioregulators (SMBs) such as nitric
oxide (NO) or carbon monoxide (CO) at physiological sites offers exquisite control of timing …
oxide (NO) or carbon monoxide (CO) at physiological sites offers exquisite control of timing …
Toll-like receptor 4 (TLR4) antagonists as potential therapeutics for intestinal inflammation
Gastrointestinal inflammation is a hallmark of highly prevalent disorders, including cancer
treatment–induced mucositis and ulcerative colitis. These disorders cause debilitating …
treatment–induced mucositis and ulcerative colitis. These disorders cause debilitating …
[HTML][HTML] Mucositis in patients with hematologic malignancies: an overview
P Niscola, C Romani, L Cupelli, L Scaramucci… - …, 2007 - haematologica.org
Mucosal barrier injury (mucositis) is a common complication of many treatments used in
hematologic malignancies, affecting most patients whose neoplasms are treated with …
hematologic malignancies, affecting most patients whose neoplasms are treated with …
Severe oral mucositis after intensity-modulated radiation therapy for head and neck cancer
Importance Oral mucositis (OM) is a common and debilitating adverse effect observed in
patients with head and neck cancer (HNC) receiving radiation therapy (RT). Previous …
patients with head and neck cancer (HNC) receiving radiation therapy (RT). Previous …
Effects of professional oral health care on reducing the risk of chemotherapy-induced oral mucositis
H Saito, Y Watanabe, K Sato, H Ikawa… - Supportive Care in …, 2014 - Springer
Purpose Recent years have seen remarkable progress in cancer therapy, although
treatment-induced adverse reactions and complications are not uncommon. Approximately …
treatment-induced adverse reactions and complications are not uncommon. Approximately …